Axiom Investors LLC Syndax Pharmaceuticals Inc Transaction History
Axiom Investors LLC
- $13.2 Billion
- Q4 2024
A detailed history of Axiom Investors LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Axiom Investors LLC holds 53,224 shares of SNDX stock, worth $790,908. This represents 0.01% of its overall portfolio holdings.
Number of Shares
53,224
Previous 115,642
53.98%
Holding current value
$790,908
Previous $2.23 Million
68.42%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding SNDX
# of Institutions
232Shares Held
93.8MCall Options Held
1.01MPut Options Held
692K-
Black Rock Inc. New York, NY7.91MShares$117 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.95MShares$88.4 Million0.01% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.84MShares$86.8 Million9.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.88MShares$72.5 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$62.9 Million0.01% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $841M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...